Fortress Biotech
FBIO
48 hedge funds and large institutions have $15.9M invested in Fortress Biotech in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 19 reducing their positions, and 20 closing their positions.
69% more call options, than puts
Call options by funds: $759K | Put options by funds: $449K
16% less funds holding
Funds holding: 57 → 48 (-9)
29% less capital invested
Capital invested by funds: $22.3M → $15.9M (-$6.44M)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
53% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$564K |
| 2 |
Morgan Stanley
New York
|
+$326K |
| 3 |
Millennium Management
New York
|
+$300K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$261K |
| 5 |
Renaissance Technologies
New York
|
+$231K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.73M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.28M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$601K |
| 4 |
State Street
Boston,
Massachusetts
|
-$541K |
| 5 |
MOACM
Mutual of America Capital Management
New York
|
-$285K |
FBIO Hedge Fund Activity: Q2 2014 in Review
48 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2014, worth a combined $15.9M — down 29% from $22.3M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of FBIO and 11 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, adding an estimated $564K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $1.73M sold.
- 48 institutional investors held Fortress Biotech (FBIO) as of Q2 2014, down from 57 in Q1 2014.
- Funds reported $15.9M of Fortress Biotech stock for Q2 2014, down 29% quarter-over-quarter.
- 11 funds opened new Fortress Biotech positions in Q2 2014 and 20 closed out, a net change of -9 holders.
- The largest Fortress Biotech buyer in Q2 2014 was Susquehanna International Group, an estimated $564K added.
- The largest Fortress Biotech seller in Q2 2014 was Nantahala Capital Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q2 2014.